Prostate cancer genetic region mapped.While no one has yet identified a specific genetic defect that causes prostate cancer prostate cancer, cancer originating in the prostate gland. Prostate cancer is the leading malignancy in men in the United States and is second only to lung cancer as a cause of cancer death in men. , scientists have mapped three locations on chromosomes that probably harbor mutations predisposing a man to the malignancy. A fourth such location was unveiled at the meeting, and it contains a twist. Having a genetic defect in a specific area on chromosome 1 seems to boost the risk not only of prostate cancer but of brain cancer, too. Researchers in the Seattle Prostate Cancer Genetics Consortium studied 141 extended families that each had three or more members with prostate cancer. Twelve of the families included a blood relative who had brain cancer. Members of those 12 families who had either form of cancer displayed the genetic marker genetic marker n. A gene phenotypically associated with a particular, easily identified trait and used to identify an individual or cell carrying that gene. much more often than does the general population. While there is apparently a prostate-cancer mutation at work in this region, such linkage doesn't mean that someone with prostate cancer is necessarily predisposed pre·dis·pose v. pre·dis·posed, pre·dis·pos·ing, pre·dis·pos·es v.tr. 1. a. To make (someone) inclined to something in advance: to brain cancer, says Gall P. Jarvik, a statistical geneticist ge·net·i·cist n. A specialist in genetics. geneticist a specialist in genetics. geneticist at the University of Washington Medical Center The University of Washington Medical Center is a nationally renowned hospital located in the University District of Seattle, Washington, USA. It is one of the teaching hospitals affiliated with the University of Washington School of Medicine. The 2007 issue of U.S. in Seattle. "There's not an obvious connection between prostate and brain cancers, not like breast and ovarian cancer ovarian cancer Malignant tumour of the ovaries. Risk factors include early age of first menstruation (before age 12), late onset of menopause (after age 52), absence of pregnancy, presence of specific genetic mutations, use of fertility drugs, and personal history of breast ," says Elaine A. Ostrander, a molecular biologist at the Fred Hutchinson Cancer Research Center in Seattle. However, the findings hint at disruption of a cancer-suppressor gene in this region of chromosome 1, Ostrander says. Whatever this gene is, its effects appear to be much more important for prostate cancer then brain cancer, Jarvik says. |
|
||||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion